Literature DB >> 29952925

Landscape of Living Multiorgan Donation in the United States: A Registry-Based Cohort Study.

Macey L Henderson1,2, Sandra R DiBrito1, Alvin G Thomas1, Courtenay M Holscher1, Ashton A Shaffer1,3, Mary Grace Bowring1, Tanjala S Purnell1,2, Allan B Massie1,3, Jacqueline M Garonzik-Wang1, Madeleine M Waldram1, Krista L Lentine4, Dorry L Segev1,3.   

Abstract

BACKGROUND: The donation of multiple allografts from a single living donor is a rare practice, and the patient characteristics and outcomes associated with these procedures are not well described.
METHODS: Using the Scientific Registry of Transplant Recipients, we identified 101 living multiorgan donors and their 133 recipients.
RESULTS: The 49 sequential (donations during separate procedures) multiorgan donors provided grafts to 81 recipients: 21 kidney-then-liver, 15 liver-then-kidney, 5 lung-then-kidney, 3 liver-then-intestine, 3 kidney-then-pancreas, 1 lung-then-liver, and 1 pancreas-then-kidney. Of these donors, 38% donated 2 grafts to the same recipient and 15% donated 2 grafts as non-directed donors. Compared to recipients from first-time, single organ living donors, recipients from second-time living donors had similar graft and patient survival. The 52 simultaneous (multiple donations during one procedure) multiorgan donors provided 2 grafts to 1 recipient each: 48 kidney-pancreas and 4 liver-intestine. Donors had median of 13.4 years (interquartile range, 8.3-18.5 years) of follow-up. There was one reported death of a sequential donor (2.5 years after second donation). Few postdonation complications were reported over a median of 116 days (interquartile range, 0-295 days) of follow-up; however, routine living donor follow-up data were sparse. Recipients of kidneys from second-time living donors had similar graft (P = 0.2) and patient survival (P = 0.4) when compared with recipients from first-time living donors. Similarly, recipients of livers from second-time living donors had similar graft survival (P = 0.9) and patient survival (P = 0.7) when compared with recipients from first-time living donors.
CONCLUSIONS: Careful documentation of outcomes is needed to ensure ethical practices in selection, informed consent, and postdonation care of this unique donor community.

Entities:  

Mesh:

Year:  2018        PMID: 29952925      PMCID: PMC6029711          DOI: 10.1097/TP.0000000000002082

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  27 in total

1.  Combined kidney and pancreas transplants from living donors.

Authors:  R W Gruessner; J P Leone; D E Sutherland
Journal:  Transplant Proc       Date:  1998-03       Impact factor: 1.066

2.  Living donation to the extreme: Saving a life not once, but twice.

Authors:  Nicolas Goldaracena; Nazia Selzner; Markus Selzner
Journal:  Liver Transpl       Date:  2017-03       Impact factor: 5.799

3.  Living Organ Donation and Informed Consent in the United States: Strategies to Improve the Process.

Authors:  Macey L Henderson; Jed Adam Gross
Journal:  J Law Med Ethics       Date:  2017-03       Impact factor: 1.718

4.  Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes.

Authors:  Ngan N Lam; Mark A Schnitzler; Dorry L Segev; Gregory P Hess; Bertram L Kasiske; Henry B Randall; David Axelrod; Huiling Xiao; Amit X Garg; Daniel C Brennan; Krista L Lentine
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939

Review 5.  Pushing the envelope: living donor pancreas transplantation.

Authors:  David E R Sutherland; David Radosevich; Rainer Gruessner; Angelika Gruessner; Raja Kandaswamy
Journal:  Curr Opin Organ Transplant       Date:  2012-02       Impact factor: 2.640

6.  Outcomes of various transplant procedures (single, sparing, inverted) in living-donor lobar lung transplantation.

Authors:  Hiroshi Date; Akihiro Aoyama; Kyoko Hijiya; Hideki Motoyama; Tomohiro Handa; Hideyuki Kinoshita; Shiro Baba; Toshiyuki Mizota; Kenji Minakata; Toyofumi F Chen-Yoshikawa
Journal:  J Thorac Cardiovasc Surg       Date:  2016-10-31       Impact factor: 5.209

7.  Long-term Outcomes for Living Pancreas Donors in the Modern Era.

Authors:  Varvara A Kirchner; Erik B Finger; Melena D Bellin; Ty B Dunn; Rainer W G Gruessner; Bernhard J Hering; Abhinav Humar; Aleksandra K Kukla; Arthur J Matas; Timothy L Pruett; David E R Sutherland; Raja Kandaswamy
Journal:  Transplantation       Date:  2016-06       Impact factor: 4.939

8.  Living donor pancreas transplantation in Japan.

Authors:  Takashi Kenmochi; Takehide Asano; Michihiro Maruyama; Kenichi Saigo; Naotake Akutsu; Chikara Iwashita; Kazunori Ohtsuki; Akiko Suzuki; Mariko Miyazaki
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-07-18       Impact factor: 7.027

Review 9.  Short- and long-term outcome for living pancreas donors.

Authors:  Jason F Reynoso; Christine E Gruessner; David E R Sutherland; Rainer W G Gruessner
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-08-04       Impact factor: 7.027

10.  Simultaneous pancreas-kidney transplant from living related donor: a single-center experience.

Authors:  Adam Zieliński; Sławomir Nazarewski; Diego Bogetti; Pierpaolo Sileri; Giuliano Testa; Howard Sankary; Enrico Benedetti
Journal:  Transplantation       Date:  2003-08-15       Impact factor: 4.939

View more
  2 in total

1.  Extreme living donation: A single center simultaneous and sequential living liver-kidney donor experience with long-term outcomes under literature review.

Authors:  Yücel Yankol; Cihan Karataş; Turan Kanmaz; Burak Koçak; Münci Kalayoğlu; Koray Acarlı
Journal:  Turk J Surg       Date:  2021-09-28

2.  Deceased vs living donor grafts for pediatric simultaneous liver-kidney transplantation: A single-center experience.

Authors:  Sergey Gautier; Artem Monakhov; Olga Tsiroulnikova; Mikhail Voskanov; Igor Miloserdov; Timur Dzhanbekov; Sergey Meshcheryakov; Robert Latypov; Elena Chekletsova; Olga Malomuzh; Khizri Khizroev; Deniz Dzhiner; Irina Pashkova
Journal:  J Clin Lab Anal       Date:  2020-01-22       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.